IHI: ISHARES U.S. MEDICAL DEVICES ETF
Share-split context: A forward split was recorded on Jul 19, 2021 with coefficient 6. A forward split turns each old share into multiple new shares and lowers the quoted price per share proportionally. Proportional ownership is unchanged at the split moment, so the split itself creates neither a gain nor a loss. The price-return figures in this report are already split-adjusted.
What this ETF is trying to do
The iShares U.S. Medical Devices ETF (IHI) focuses on companies that create medical tools and devices. It holds a variety of companies in this field. As of October 8, 2026, its top holdings include Abbott Laboratories (17.77%), Intuitive Surgical Inc (14.92%), and Medtronic PLC (11.47%). These top holdings represent only a part of the total 53 companies in the fund.
What the numbers show
The current price of the ETF is $50.95. Because this ETF has a history of share splits, we look at split-adjusted returns to see how it has performed.
• Year-to-Date (YTD): The price return is -18.02%, and the total return is -17.71%.
• One Year: The price return is -15.03%, and the total return is -14.61%.
• Three Year: The price return is 6.08%, and the total return is 7.56%.
• Five Year: The total return is -17.24%.
Price return only measures the change in the share price. Total return is a different measure that includes distributions.
Income and distribution explanation
This ETF usually pays distributions quarterly. Over the last 12 months, it has paid out four times. The distribution yield is 0.51%.
It is important for new investors to know that a distribution yield is not the same as a total return. A yield tells you how much cash was paid out relative to the price, but it does not guarantee that your original investment (the principal) is safe.
NAV erosion explanation
"NAV erosion" happens when the underlying value of a fund's assets declines over time. StockValueFinder uses an erosion-risk score to measure this. IHI has an erosion score of 55, which is labeled as "Moderate price erosion." While there is a moderate risk flag, the "severe erosion-risk flag" is currently false.
Share Split History
This ETF has had a forward split. On July 19, 2021, it had a split coefficient of 6. In a forward split, each old share becomes multiple new shares, and the price per share drops proportionally. This change does not create a gain or a loss; it simply changes the number of shares an investor owns.
Pros
• Provides exposure to major medical device companies.
• Positive total return over a three-year period (7.56%).
Cons
• Negative total returns over the last year and five years.
• Moderate price erosion risk.
• Low distribution yield.
Beginner takeaway
IHI allows investors to own a basket of medical device companies. While it has seen growth over three years, it has struggled recently with negative returns over the last year. Investors should remember that a low yield means this fund is not primarily designed for high cash income, and the moderate erosion score suggests a need to monitor the stability of the share price.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | ABBOTT LABORATORIES | ABT | 17.77% |
| 2 | INTUITIVE SURGICAL INC | ISRG | 14.92% |
| 3 | MEDTRONIC PLC | MDT | 11.47% |
| 4 | IDEXX LABORATORIES INC | IDXX | 4.58% |
| 5 | DEXCOM INC | DXCM | 4.55% |
| 6 | EDWARDS LIFESCIENCES CORP | EW | 4.52% |
| 7 | STRYKER CORP | SYK | 4.51% |
| 8 | BECTON DICKINSON & CO | BDX | 4.49% |
| 9 | RESMED INC | RMD | 4.46% |
| 10 | BOSTON SCIENTIFIC CORP | BSX | 4.38% |